We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senators Ask FTC to Analyze How Pay-For-Delay Deals Affect Biosimilar Access
Senators Ask FTC to Analyze How Pay-For-Delay Deals Affect Biosimilar Access
The Federal Trade Commission should examine the impact of “pay-for-delay” deals on the availability of cheaper biosimilars, two U.S. senators said in a letter Friday.